-
71.发明公开OPTISCH ANSTEUERBARE MIKROELEKTRODENANORDNUNG ZUM STIMULIEREN VON ZELLEN, INSBESONDERE RETINA-IMPLANTAT 失效光寻址微电极排列，刺激细胞，尤其是视网膜植入物
公开(公告)号：EP0951312A1
公开(公告)日：1999-10-27
申请号：EP97945845.0
申请日：1997-10-16
发明人： NISCH, Wilfried , STELZLE, Martin , WEISS, Stefan , ZRENNER, Eberhard , GÜNTHER, Elke , STETT, Alfred , GRAF, Heinz, Gerhard , GRAF, Michael , SCHUBERT, Markus, B. , WANKA, Harald, N. , HIERZENBERGER, Anke
CPC分类号： A61N1/36046 , A61F9/08 , A61N1/05 , A61N1/326
摘要： The invention concerns an optically controllable microelectrode arrangement for stimulating cells (27), in particular a retina implant. This arrangement comprises a surface (28) abutting a tissue, for example a retina (12), containing the cells (27). The surface (28) is provided with electrodes (35a) for stimulating tissue cells (27). The electrodes (35a) are controlled by light (21, 22) impinging on the tissue such that the electrode (35a) exerts an electrical stimulus (41) on the cell (27). The surface (d) of the electrode (35a) used for contact with a cell (27) is substantially smaller than the surface (B) of the cell (27) used for contact with the electrode (35a).
-
公开(公告)号：EP0948642A1
公开(公告)日：1999-10-13
申请号：EP97909359.0
申请日：1997-10-04
发明人： EINSELE, Hermann , LÖFFLER, Jürgen
CPC分类号： C12Q1/6895 , C12Q2600/156
摘要： The invention relates to a method for detecting resistant fungi cells in clinical material. According to said method, fungi-specific nucleic acids are initially extracted from the clinical material and subsequently hybridized with fungi-specific hybridization probes which are targeted against nucleic acid segments of azole derivative-resistant fungi cells.
-
73.发明授权
公开(公告)号：EP0711565B1
公开(公告)日：1998-08-26
申请号：EP95117465.5
申请日：1995-11-07
IPC分类号： A61K39/395 , A61K48/00 , G01N33/574
CPC分类号： C07K16/32 , A61K39/39558
-
公开(公告)号：EP2828663B1
公开(公告)日：2018-09-26
申请号：EP13720803.9
申请日：2013-03-22
IPC分类号： G01N33/569
CPC分类号： C12N5/0663 , A61K35/28 , A61K2035/124 , A61K2039/507 , C07K16/28 , C07K16/2803 , C07K16/2863 , C07K16/40 , G01N33/56966 , G01N2333/705 , G01N2333/70503 , G01N2333/71 , G01N2333/916
-
公开(公告)号：EP2734203B1
公开(公告)日：2016-07-06
申请号：EP12735554.3
申请日：2012-07-17
IPC分类号： A61K47/02 , A61K31/43 , A61K31/7036 , A61K38/12 , A61P11/00 , A61P31/00 , A61P31/04 , A61K9/00
CPC分类号： A61K31/43 , A61K9/0078 , A61K31/7036 , A61K38/12 , A61K47/02 , A61K2300/00
-
公开(公告)号：EP2828663A2
公开(公告)日：2015-01-28
申请号：EP13720803.9
申请日：2013-03-22
IPC分类号： G01N33/569
CPC分类号： C12N5/0663 , A61K35/28 , A61K2035/124 , A61K2039/507 , C07K16/28 , C07K16/2803 , C07K16/2863 , C07K16/40 , G01N33/56966 , G01N2333/705 , G01N2333/70503 , G01N2333/71 , G01N2333/916
摘要： The present invention relates to the use of at least one antibody which binds to the SUSD2 antigen, or to functional fragments of the antibody, in combination with at least one of the following: an antibody which binds to CD140b, an antibody which binds to CD56, and/or an antibody which binds to TNAP, or functional fragments thereof, for isolation of mesenchymal stem cells, especially those having particularly chondrocytic and osteogenic differentiation potential. The invention further relates to processes for isolating such stem cells using these antibodies.
-
77.发明公开HÖRGERÄT UND VERFAHREN ZUM ELIMINIEREN AKUSTISCHER RÜCKKOPPLUNGEN BEI VERSTÄRKUNG AKUSTISCHER SIGNALE 审中-公开助听器和方法消除声反馈，以加强声音信号
公开(公告)号：EP2730100A1
公开(公告)日：2014-05-14
申请号：EP12731461.5
申请日：2012-07-04
发明人： GOLL, Erich , DALHOFF, Ernst , ZENNER, Hans-Peter
IPC分类号： H04R25/00
CPC分类号： H04R25/453 , H04R25/45 , H04R25/50 , H04R25/70 , H04R2225/43
摘要： The invention relates to a method for setting a frequency-dependent amplification of a hearing aid (30), wherein the amplification is automatically adjusted according to the frequency. The method comprises the following steps: selecting a sound having specific frequency (f1...fn); outputting the sound by means of a transmission element (42), in particular a speaker; detecting an analysis noise, which comprises an ambient noise (32), if present, and a reflection (48) of an output noise (46), which is output by means of the transmission element (42), by means of a sensor element (34), in particular a microphone; extracting a rejection of the fed-in sound from the detected analysis noise; determining a reflection component (S1...Sn) for the specific frequency (f1...fn) of the fed-in sound; and adapting the amplification in a frequency-specific manner on the basis of the reflection component determined in such a way.
摘要翻译： 在具有麦克风的助听器，以在使用者的身体被布置用于捕获环境声音，用于输出铃声的扬声器具有被放大的频率依赖性的基础上后的环境声音，以及信号处理器，所述信号处理器被配置为 放大声音检测所做的放大的声音是可听给用户，并自动重新调整增益通过以下步骤：选择具有特定频率的音调; 输出铃声音调，并且经由扬声器以输出声音被放大的环境声音; 通过在所述输出声音的反射的环境声音的和由声音分析所述麦克风捕获; 提取从捕获的声音分析音调的反射; 和确定性采矿为基调的特定频率的反射成分; 调节特定频率的方式的增益和基于确定性开采反射分量。
-
公开(公告)号：EP2576771A2
公开(公告)日：2013-04-10
申请号：EP11725901.0
申请日：2011-06-07
发明人： AICHER, Wilhelm , ANGRES, Brigitte
IPC分类号： C12N5/0775
CPC分类号： C07K7/06 , A61K35/28 , A61K38/00 , A61K2035/124 , A61L31/08 , A61L31/16 , C07K5/0808 , C07K5/1008 , C07K5/101 , C07K5/1016 , C07K7/08 , C07K14/47 , C07K14/78 , C12N5/0068 , C12N5/0663 , C12N5/0668 , C12N2533/00 , C12N2533/52 , C12N2533/54
摘要： The present invention relates to the use of a peptide selected from the group comprising laminin-1, collagen-1, collagen-3, collagen-4, tenascin, thrombospondin-1, osteopontin, fibronectin, vitronectin, or fragments or mixtures of these, for isolating and/or identifying mesenchymal stem cells (MSC), in particular of peptide fragments of these peptides. The invention furthermore relates to the use of these peptides/peptide fragments in the treatment of wounds, injuries and/or degenerated tissue.
-
公开(公告)号：EP2572184A1
公开(公告)日：2013-03-27
申请号：EP11714037.6
申请日：2011-04-12
发明人： MOEHRLE, Matthias
摘要： The invention relates to a method for the visual examination of biological material
ex vivo and to a device for the spatial orientation of biological material which device can be used in said method.-
80.发明公开Verwendung von Substanzen, die den zellulären Glutathion-Gehalt absenken, zur Herstellung eines Arzneimittels zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten 有权的其降低细胞谷胱甘肽含量的物质的用途，介导的药物中的用途为T细胞自体免疫疾病的治疗
公开(公告)号：EP2428208A3
公开(公告)日：2012-12-26
申请号：EP11008821.8
申请日：2007-10-31
CPC分类号： A61K31/167 , A61K31/198 , A61K31/22 , A61K31/675 , G01N33/5047
摘要： Die vorliegende Erfindung betrifft eine Verfahren zur Bestimmung des Potentials von pharmazeutischen Substanzen, den zellulären Glutathiongehalt zu senken und/oder den zellulären ROS-Gehalt zu steigern; die derart identifizierten Substanzen, die den zellulären GSH-Level absenken, können zur Behandlung von T-Zell vermittelten Autoimmunkrankheiten eingesetzt werden.
-
-
-
-
-
-
-
-
-
搜索结果
135 条记录 (耗时 0.02 秒)
